Patients with acute spinal cord injury benefit from normocapnic hyperpnoea training.
DOI:
https://doi.org/10.2340/16501977-0140Keywords:
respiratory muscle training, randomized controlled trial, paraplegia, quadriplegia.Abstract
BACKGROUND: Functional loss of respiratory muscles in persons with spinal cord injury leads to impaired pulmonary function and respiratory complications. In addition, respiratory complications are responsible for 50-67% of the morbidity in this population. OBJECTIVE: To investigate the effects of normocapnic hyperpnoea training in acute spinal cord injury. PATIENTS AND METHODS: Fourteen patients were randomized between control (sham) and an experimental normocapnic hyperpnoea training group. Vital capacity, maximal voluntary ventilation, respiratory muscle strength and endurance, respiratory complications and symptoms were evaluated before, after 4 and 8 weeks of training and after 8 weeks follow-up. RESULTS: Maximal voluntary ventilation, respiratory muscle strength and endurance improved significantly in the experimental group compared with the control group (p < 0.05). Improvements in vital capacity tended to be different from the control group at 8 weeks of training. The Index of Pulmonary Dysfunction decreased after 4 weeks of training and respiratory complications were reported less frequently in the experimental group compared with the control group. CONCLUSION: Normocapnic hyperpnoea training in patients with spinal cord injury improved respiratory muscle strength and endurance. Respiratory complications occurred less frequently after training.Downloads
Downloads
Published
How to Cite
Issue
Section
License
All digitalized JRM contents is available freely online. The Foundation for Rehabilitation Medicine owns the copyright for all material published until volume 40 (2008), as from volume 41 (2009) authors retain copyright to their work and as from volume 49 (2017) the journal has been published Open Access, under CC-BY-NC licences (unless otherwise specified). The CC-BY-NC licenses allow third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
From 2024, articles are published under the CC-BY licence. This license permits sharing, adapting, and using the material for any purpose, including commercial use, with the condition of providing full attribution to the original publication.
